---
title: "Methamphetamine - Attention Deficit Hyperactivity Disorder"
sidebar: mydoc_sidebar
permalink: db01577-mesh-d001289-1.html
toc: false 
---


Path ID: `DB01577_MESH_D001289_1`
{% include image.html url="images/db01577-mesh-d001289-1.png" file="db01577-mesh-d001289-1.png" alt="db01577-mesh-d001289-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D008694">MESH:D008694 </a> | Methamphetamine | Drug |
| <a href="https://identifiers.org/UniProt:P23975">UniProt:P23975 </a> | Sodium-dependent noradrenaline transporter | Protein |
| <a href="https://identifiers.org/UniProt:Q01959">UniProt:Q01959 </a> | Sodium-dependent dopamine transporter | Protein |
| <a href="https://identifiers.org/UniProt:P27338">UniProt:P27338 </a> | Amine oxidase B | Protein |
| <a href="https://identifiers.org/UniProt:P21397">UniProt:P21397 </a> | Amine oxidase A | Protein |
| <a href="https://identifiers.org/GO:0051620">GO:0051620 </a> | Noradrenaline uptake | BiologicalProcess |
| <a href="https://identifiers.org/GO:0051583">GO:0051583 </a> | Dopamine uptake involved in synaptic transmission | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D009638">MESH:D009638 </a> | Noradrenaline | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D004298">MESH:D004298 </a> | Dopamine | ChemicalSubstance |
| <a href="https://identifiers.org/GO:0061533">GO:0061533 </a> | Norepinephrine secretion, neurotransmission | BiologicalProcess |
| <a href="https://identifiers.org/GO:0061527">GO:0061527 </a> | Dopamine secretion, neurotransmission | BiologicalProcess |
| <a href="https://identifiers.org/MESH:D001289">MESH:D001289 </a> | Attention deficit hyperactivity disorder | ChemicalSubstance |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Methamphetamine | DECREASES ACTIVITY OF | Sodium-Dependent Noradrenaline Transporter |
| Methamphetamine | DECREASES ACTIVITY OF | Sodium-Dependent Dopamine Transporter |
| Methamphetamine | DECREASES ACTIVITY OF | Amine Oxidase B |
| Methamphetamine | DECREASES ACTIVITY OF | Amine Oxidase A |
| Sodium-Dependent Noradrenaline Transporter | PARTICIPATES IN | Noradrenaline Uptake |
| Sodium-Dependent Dopamine Transporter | PARTICIPATES IN | Dopamine Uptake Involved In Synaptic Transmission |
| Amine Oxidase B | DECREASES ABUNDANCE OF | Noradrenaline |
| Amine Oxidase B | DECREASES ABUNDANCE OF | Dopamine |
| Amine Oxidase A | DECREASES ABUNDANCE OF | Dopamine |
| Amine Oxidase A | DECREASES ABUNDANCE OF | Noradrenaline |
| Noradrenaline Uptake | DECREASES ABUNDANCE OF | Noradrenaline |
| Dopamine Uptake Involved In Synaptic Transmission | DECREASES ABUNDANCE OF | Dopamine |
| Noradrenaline | PARTICIPATES IN | Norepinephrine Secretion, Neurotransmission |
| Dopamine | PARTICIPATES IN | Dopamine Secretion, Neurotransmission |
| Norepinephrine Secretion, Neurotransmission | DISRUPTED BY | Attention Deficit Hyperactivity Disorder |
| Dopamine Secretion, Neurotransmission | DISRUPTED BY | Attention Deficit Hyperactivity Disorder |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB01577#BE0001044](https://go.drugbank.com/drugs/DB01577#BE0001044)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626918/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2626918/)
